Related Experiment Video
Updated: Dec 20, 2025
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes
Guimiao Lin1, Chengbin Yang, Rui Hu
1School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore 639798, Singapore. ktyong@ntu.edu.sg.
Abstract:
Pancreatic cancer is one of the deadliest cancers throughout the world with rarely efficient therapies currently available. Gene therapy on pancreatic cancer through small interfering RNA (siRNA)-based RNA interference (RNAi) has shown great potential and attracted much attention. However, due to the fragile nature of nucleic acid, the application of RNAi as a safe and efficient carrier faces great challenges. In this contribution, a self-assembly regime, which is based on well-defined cationic polylactides (CPLAs) with tertiary amine groups, has been used to encapsulate and protect siRNAs from fast degradation. CPLA is a safe and degradable formulation that allowed us to deliver siRNAs targeting the proangiogenic chemokine interleukin-8 (IL-8) to pancreatic cancer cells for gene therapy. Stable IL-8 siRNA-CPLA nanoplexes were successfully formed by electrostatic force and high gene transfection efficiencies were shown on two pancreatic cancer cell lines. We did not observe any cytotoxicity from these CPLAs over a large concentration range via cell viability evaluations. More importantly, the silencing of IL-8 gene expression significantly attenuated the proliferation of pancreatic cancer cells. Our preliminary results support the future development of gene therapy that might provide an effective and safe treatment approach towards pancreatic cancer.
Insights
Cationic polylactides (CPLAs) effectively deliver small interfering RNA (siRNA) to pancreatic cancer cells, protecting it from degradation. This gene therapy approach safely reduced tumor cell proliferation by silencing the interleukin-8 (IL-8) gene.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic cancer remains a highly lethal malignancy with limited effective treatments.
- Gene therapy using small interfering RNA (siRNA)-based RNA interference (RNAi) shows promise but faces delivery challenges due to nucleic acid fragility.
Purpose of the Study:
- To develop a safe and effective delivery system for siRNA-based gene therapy in pancreatic cancer.
- To evaluate the potential of cationic polylactides (CPLAs) for encapsulating and delivering siRNA targeting interleukin-8 (IL-8).
Main Methods:
- Self-assembly of well-defined CPLAs with tertiary amine groups to encapsulate IL-8 siRNA.
- Formation of stable IL-8 siRNA-CPLA nanoplexes via electrostatic interactions.
- Assessment of gene transfection efficiency and cytotoxicity in pancreatic cancer cell lines.
- Evaluation of IL-8 gene silencing and its effect on cancer cell proliferation.
Main Results:
- Stable nanoplexes of IL-8 siRNA and CPLA were successfully formed.
- High gene transfection efficiencies were observed in two pancreatic cancer cell lines.
- CPLAs exhibited no significant cytotoxicity across a wide concentration range.
- Silencing of IL-8 gene expression significantly inhibited pancreatic cancer cell proliferation.
Conclusions:
- CPLAs provide a safe and degradable formulation for delivering siRNA in pancreatic cancer gene therapy.
- The developed IL-8 siRNA-CPLA nanoplexes demonstrate potential for effective pancreatic cancer treatment.
- Further development of this gene therapy approach may offer a safe and effective therapeutic strategy for pancreatic cancer.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
09:01Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013